Advanced

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

Labaf, Ashkan LU ; Carlwe, Martin and Svensson, Peter LU (2014) In Thrombosis Journal 12(1).
Abstract
In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Thrombosis Journal
volume
12
issue
1
publisher
BioMed Central
external identifiers
  • pmid:25506268
  • scopus:84924107218
ISSN
1477-9560
DOI
10.1186/s12959-014-0029-6
language
English
LU publication?
yes
id
f888bfbe-d101-4585-9287-9c9ffc5af7bd (old id 4908246)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25506268?dopt=Abstract
date added to LUP
2015-01-11 19:46:10
date last changed
2017-06-25 03:55:41
@article{f888bfbe-d101-4585-9287-9c9ffc5af7bd,
  abstract     = {In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.},
  articleno    = {29},
  author       = {Labaf, Ashkan and Carlwe, Martin and Svensson, Peter},
  issn         = {1477-9560},
  language     = {eng},
  number       = {1},
  publisher    = {BioMed Central},
  series       = {Thrombosis Journal},
  title        = {Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.},
  url          = {http://dx.doi.org/10.1186/s12959-014-0029-6},
  volume       = {12},
  year         = {2014},
}